Lyra Therapeutics (LYRA) Other Operating Expenses (2022 - 2025)
Quarterly Other Operating Expenses fell 675.0% to -$31000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$46000.0 through Dec 2025, down 100.19% year-over-year, with the annual reading at -$31000.0 for FY2025, 100.13% down from the prior year.
Lyra Therapeutics' Other Operating Expenses history spans 4 years, with the latest figure at -$31000.0 for Q4 2025.
- Other Operating Expenses came in at -$31000.0 for Q4 2025, down from -$15000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $24.7 million in Q2 2024 to a low of -$31000.0 in Q4 2025.
- The 4-year median for Other Operating Expenses is $656000.0 (2022), against an average of $4.6 million.
- Year-over-year, Other Operating Expenses surged 1452.7% in 2024 and then plummeted 675.0% in 2025.
- Lyra Therapeutics' Other Operating Expenses stood at $1.3 million in 2022, then grew by 20.97% to $1.6 million in 2023, then plummeted by 100.25% to -$4000.0 in 2024, then tumbled by 675.0% to -$31000.0 in 2025.
- Per Business Quant, the three most recent readings for LYRA's Other Operating Expenses are -$31000.0 (Q4 2025), -$15000.0 (Q1 2025), and -$4000.0 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Lyra Therapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31,000.00 |
| Mar 31, 2025 | -15,000.00 |
| Dec 31, 2024 | -4,000.00 |
| Jun 30, 2024 | 24.72 Mn |
| Jun 30, 2023 | 1.59 Mn |
| Dec 31, 2022 | 1.32 Mn |